Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-04-29

Clinical Trial Update: Effects of Treatment With N- Acetylcysteine on Visual Outcomes in Patients With Retinitis Pigmentosa [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the effects of N-acetylcysteine on visual outcomes in patients with retinitis pigmentosa.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Shahid Beheshti University of Medical Sciences | Conditions: Retinitis Pigmentosa | Phase 2 | Status: UNKNOWN